CARsgen Therapeutics climbs on board nod for share buyback
26/06/2026 06:39
BUZZ-CARsgen Therapeutics climbs on board nod for share buyback ** Shares of CARsgen Therapeutics Holdings 2171.HK climb 3.9% to HK$12.9, on track to snap three straight sessions of declines
** Chinese cell therapies developer says its board of directors has approved its repurchase of shares of up to 5% of the total issued share capital in the open market
** Funds to be used for the share repurchase come from non-IPO raised funds, including business development income, interest income, and other subsidy - co
** YTD, stock down 13.6%, Hang Seng Biotech Index .HSBIO down 14.5%
(Reporting by Donny Kwok)
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer